New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
09:35 EDTALKSAlkermes downgraded to Neutral from Buy at MKM Partners (pre-open)
MKM Partners downgraded Alkermes based on valuation. Price target is $23.
News For ALKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
06:51 EDTALKSAlkermes concerns removed with FDA acceptance, says Citigroup
Subscribe for More Information
October 22, 2014
07:02 EDTALKSAlkermes aripiprazole lauroxil NDA accepted for filing by FDA
Subscribe for More Information
October 21, 2014
07:54 EDTALKSLeerink a buyer of Alkermes, ImmunoGen, Incyte
Subscribe for More Information
October 14, 2014
07:15 EDTALKSBiotech Industry Organization to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use